Prof. Chuanben Chen 陈传本
Chief Physician, Professor
Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of head and neck malignancies, especially nasopharyngeal cancer. Expertise includes comprehensive therapy, brachytherapy, and stereotactic conformal intensity-modulated radiation therapy.
Dr. Chen is President of Fujian Cancer Hospital, Chief Physician, and Professor at Fujian Medical University. A graduate of Fujian Medical University (1986), Dr. Chen specializes in tumor radiotherapy. The doctor has published over 30 papers and received provincial awards for scientific progress, employee technological invention, and medical technology.
Professional roles
- Member, Oncology Branch, Chinese Medical Association
- Vice Chair, Nasopharyngeal Cancer Professional Committee, Fujian Anti-Cancer Association
- Deputy Director, Fujian Radiotherapy Quality Control Center
- Standing Committee Member and Secretary, Tumor Radiotherapy Branch, Fujian Medical Association
Name order: in Chinese the family name comes first (Chen Chuanben). Papers usually list the name as Chuanben Chen or Chen C.
Selected publications
97 papers on PubMed matched by name and affiliation; 55 as first or senior author since 2016. Most recent first- or senior-author papers:
- Metabolites, 2026 (senior author): Integrated Serum and Spatial Metabolomics Reveals Compartmentalized Metabolic Reprogramming and Ferroptosis Susceptibility in Nasopharyngeal Carcinoma. PubMed 42941258
- Cancer Epidemiol, 2025 (senior author): A population-based analysis of cancer survival in Fujian Province, southeast China during 2021-2023. PubMed 40527231
- Curr Oncol, 2025 (senior author): Insights into the Prognostic Efficacy of the Geriatric Nutritional Risk Index for Nasopharyngeal Carcinoma in the Era of Volumetric Modulated Arc Therapy: A Nomogram for Predicting Long-Term Survival Outcomes. PubMed 40710183
- Nat Commun, 2024 (senior author): Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial. PubMed 39402023
- Acta Otorhinolaryngol Ital, 2024 (senior author): Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma. PubMed 39526766
- EBioMedicine, 2024 (senior author): Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection. PubMed 39265506
- Braz J Otorhinolaryngol, 2024 (senior author): Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram. PubMed 38101121
- Clin Epidemiol, 2024 (senior author): Cancer Survival Trends in Southeastern China, 2011-2021: A Population-Based Study. PubMed 38318284
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion